CareLit · DOI-Nachweis · Pneumologie
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
DOI 10.1055/s-0039-1678042
Bibliografische Angaben
Nachweis in CareLit
Autor:innenE Beck, A Kaplan, JM Fitzgerald, GE Azzi, M Engel, R Buhl
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review
Zitieren
Zitierempfehlung
E Beck, A Kaplan, JM Fitzgerald, GE Azzi, M Engel, R Buhl (2019) Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review. Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678042
Mit CareLit weiterarbeiten